Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +3.03% | +17.24% | +8.97% |
Apr. 25 | Compass Therapeutics Gets FDA Fast-Track Designation for Biliary Tract Cancer Treatment | MT |
Apr. 25 | Compass Therapeutics Gets FDA Fast-Track for Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.97% | 234M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- EF Hutton Initiates Compass Therapeutics at Buy With $10.30 Price Target